Singapore has one of the highest life expectancies in the world, yet many individuals spend almost a decade in poor health ...
MedPage Today on MSN
First Drug for Deadly Transplant Complication Gets FDA's Blessing
The FDA has approved narsoplimab (Yartemlea) as the first treatment for hematopoietic stem cell transplant (HSCT)-associated ...
Home warranty vs. home insurance, what's the difference? One covers normal wear and tear and the other liability and ...
The Times of Israel on MSN
Defense Ministry hands IDF first combat-ready Iron Beam laser interception system
High-power aerial defense system has successfully intercepted rockets, mortars and drones in testing, is set to be absorbed ...
Verywell Health on MSN
What Happens to Your Immunity When You Take Elderberry and Zinc Together
Elderberry and zinc both support immune health, but what happens when you combine them? Learn how these supplements work together to strengthen immunity.
A Family Chiropractic Clinic Expands IV Therapy Services to Support Winter Wellness in Denton, Texas
A Family Chiropractic Clinic announced the expansion of its clinical service offerings to include IV therapy and IV treatments at its Denton, Texas location, responding to increasing patient demand ...
Pain represents the cardinal symptom of osteoarthritis, yet its intensity, quality, and impact vary dramatically among ...
Mitsubishi Power, a power solutions brand of Mitsubishi Heavy Industries, Ltd. (MHI), and Mitsubishi Electric Corporation (Mitsubishi Electric) have completed functional testing of their jointly ...
Spain's central bank offers an interesting view inside of what the Eurosystem is building around blockchain and ...
Zacks Investment Research on MSN
Omeros gets FDA approval for YARTEMLEA as first therapy for TA-TMA
Omeros Corporation OMER recently announced that the FDA approved its YARTEMLEA (narsoplimab-wuug) to treat hematopoietic stem ...
Kees Smit Transfer Race Intensifies as Newcastle and Crystal Palace Track AZ Alkmaar ProdigyKees Smit has moved rapidly from ...
MedPage Today on MSN
FcRn Blockers Vie to Become First Approved Drug for Sjogren's Disease
FcRn blockers are approved for other indications: efgartigimod for adults with generalized myasthenia gravis and in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results